The special equipment required for manufacturing of sterile products (bhasma, ghanstva, eyedrop, capsule, etc.) includes component washing machines, steam sterilizers, membrane filter machines, manufacturing vessels, blenders, liquid filling machines, powder filling machines, sealing and labelling machines, vacuum tsting chambers, inspection machines, lyophilisers, pressure vessels, etc. are provided depending on the type and volume of activity.
Unit sterilizers are double ended with suitable interlocking arrangements between the doors. The effectiveness of the sterilization process is established initially by biological inactivation studies using microbial spore indicators and then at least oncea year by carrying out thermal mapping of the chamber.
Filling machines are challenged initially and then at periodic intervals by stimulation trials including sterile media fill.
On procurement, engineers with the support of production and quality assurance personnel have done installation qualification of each of the equipment. Equipment for critical processes like aseptic filling and sterilizers are suitably validated according to a written programme before putting them to use.
Standard operating procedures are available for each equipment for its calibration and operation and cleaning.
With FY14 revenue of Rs 1200 crore (Rs 12b), Patanjali Ayurveda Limited (PAL) has rapidly emerged as one of India’s largest Ayurveda companies.
Having started in 2006, the company has grown at a CAGR of over 80% over FY09-FY14. FY14 revenue growth was around 42%, a reflection of the challenges of growing on a higher base.
Neverthelesss, it is a remarkable achievement considering its parentage. It is backed by people who would seemingly be out of place in a business environment. PAL’s inspiration is Baba Ramdev, a reknowned Yoga and fitness guru, who commands a vast following in North India. But the Baba has no direct ownership of the company. The shareholding is held by an Ayurveda ‘Acharya’, schooled in traditional Gurukul sytem of education.
As per media reports, the company is set to grow over 60% in FY15 as well, to cross Rs 2000 crore revenue, from a base of Rs 1200 crore in FY13.